1. Home
  2. EXAS vs EDU Comparison

EXAS vs EDU Comparison

Compare EXAS & EDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • EDU
  • Stock Information
  • Founded
  • EXAS 1995
  • EDU 1993
  • Country
  • EXAS United States
  • EDU China
  • Employees
  • EXAS N/A
  • EDU N/A
  • Industry
  • EXAS Medical Specialities
  • EDU Other Consumer Services
  • Sector
  • EXAS Health Care
  • EDU Real Estate
  • Exchange
  • EXAS Nasdaq
  • EDU Nasdaq
  • Market Cap
  • EXAS 9.1B
  • EDU 7.7B
  • IPO Year
  • EXAS N/A
  • EDU 2006
  • Fundamental
  • Price
  • EXAS $45.60
  • EDU $48.41
  • Analyst Decision
  • EXAS Strong Buy
  • EDU Hold
  • Analyst Count
  • EXAS 22
  • EDU 5
  • Target Price
  • EXAS $66.43
  • EDU $51.60
  • AVG Volume (30 Days)
  • EXAS 3.9M
  • EDU 1.8M
  • Earning Date
  • EXAS 08-06-2025
  • EDU 07-30-2025
  • Dividend Yield
  • EXAS N/A
  • EDU 1.20%
  • EPS Growth
  • EXAS N/A
  • EDU 27.50
  • EPS
  • EXAS N/A
  • EDU 2.29
  • Revenue
  • EXAS $2,939,949,000.00
  • EDU $4,900,262,000.00
  • Revenue This Year
  • EXAS $14.61
  • EDU $12.40
  • Revenue Next Year
  • EXAS $12.71
  • EDU $12.56
  • P/E Ratio
  • EXAS N/A
  • EDU $21.09
  • Revenue Growth
  • EXAS 12.55
  • EDU 13.60
  • 52 Week Low
  • EXAS $38.81
  • EDU $40.66
  • 52 Week High
  • EXAS $72.83
  • EDU $87.26
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 44.47
  • EDU 55.11
  • Support Level
  • EXAS $40.55
  • EDU $46.05
  • Resistance Level
  • EXAS $45.45
  • EDU $46.90
  • Average True Range (ATR)
  • EXAS 2.04
  • EDU 1.42
  • MACD
  • EXAS 0.07
  • EDU 0.38
  • Stochastic Oscillator
  • EXAS 63.10
  • EDU 89.87

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About EDU New Oriental Education & Technology Group Inc.

New Oriental is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation, consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.

Share on Social Networks: